Deep Track Capital’s Definium Therapeutics DFTX Stock Holding History

Deep Track Capital’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.7M	Buy	3,000,000 +1,323,460	+79%	+$22.5M	0.93%	31
2025 Q4	$22.4M	Buy	1,676,540 +176,540	+12%	+$2.18M	0.4%	39
2025 Q3	$17.7M	Sell	1,500,000 -1,000,000	-40%	-$9.33M	0.49%	38
2025 Q2	$16.2M	Hold	2,500,000	–	–	0.52%	39
2025 Q1	$14.6M	Sell	2,500,000 -316,594	-11%	-$2.27M	0.47%	45
2024 Q4	$19.6M	Sell	2,816,594 -4,248,505	-60%	-$29.2M	0.73%	37
2024 Q3	$40.2M	Buy	7,065,099 +961,282	+16%	+$6.69M	1.28%	28
2024 Q2	$44M	Sell	6,103,817 -562,850	-8%	-$4.92M	1.31%	29
2024 Q1	$62.7M	Buy	+6,666,667	New	+$38M	1.8%	20

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Deep Track Capital's DFTX Position: Q1 2026 in Review

Deep Track Capital increased its Definium Therapeutics (DFTX) stake by 79% in Q1 2026, buying an estimated $22.5M and bringing the position to 3,000,000 shares worth $56.7M. The position accounts for 0.93% of the portfolio, ranked #31.

Deep Track Capital first reported a position in DFTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $62.7M in Q1 2024. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

Deep Track Capital held 3,000,000 shares of Definium Therapeutics worth $56.7M as of Q1 2026.
Deep Track Capital bought 1,323,460 Definium Therapeutics shares in Q1 2026, an estimated $22.5M.
Definium Therapeutics made up 0.93% of Deep Track Capital's portfolio in Q1 2026, its #31 holding.
Deep Track Capital first reported a position in Definium Therapeutics in Q1 2024 and has held it in 9 quarters since.
Deep Track Capital's Definium Therapeutics position peaked at $62.7M in Q1 2024.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.